TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 1 | 5 | -13 | -45 | -40 | 15 | -13 |
| P | %wins | 67 | 33 | 33 | 0 | 33 | 67 | 39 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/18/16 11:10 | 2/18/16 | CTRV | Contravir Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sapirstein James | NJ | DO | CEO | P | 10 | 1.00 | 0 | 10 | 333 | 13 | D | -36 | -75 | -78 | -35 | -33 | 5 | 2 | 14 | 4 | -2 | 14 | -13 | 7 | 56 |
12/1/15 16:05 | 11/30/15 | CTRV | Contravir Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sapirstein James | NJ | DO | CEO | P | 1 | 2.15 | 1 | 1 | 20 | 3 | D | 67 | -37 | -40 | -3 | 31 | 40 | 15 | -2 | -10 | -37 | -65 | -68 | -15 | |
11/24/15 16:15 | 11/23/15 | CTRV | Contravir Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sapirstein James | NJ | DO | CEO | P | 4 | 1.64 | 1 | 3 | New | 3 | D | 42 | -49 | -54 | -36 | -7 | 15 | 10 | 1 | 26 | -17 | -58 | -59 | 4 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |